US 11332721
Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
granted A61KA61K2039/522A61K2039/5254
Quick answer
US patent 11332721 (Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K2039/522, A61K2039/5254, A61K2039/543, A61K39/12